Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System

被引:14
|
作者
Alva, Shridhara [1 ]
Brazg, Ronald [2 ]
Castorino, Kristin [3 ]
Kipnes, Mark [4 ]
Liljenquist, David R. [5 ]
Liu, Hanqing [1 ]
机构
[1] Abbott Diabet Care, Alameda, CA 94502 USA
[2] Rainier Clin Res Ctr, Renton, WA USA
[3] Sansum Diabet Res Inst, Santa Barbara, CA USA
[4] Diabet & Glandular Dis Clin, San Antonio, TX USA
[5] Rocky Mt Diabet Ctr, Idaho Falls, ID USA
关键词
FSL3 CGM system; FSL2 CGM system; Continuous glucose monitoring; Self-monitoring blood glucose; YSI reference;
D O I
10.1007/s13300-023-01385-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionWe have evaluated the performance of the FreeStyle Libre (R) 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged >= 6 years and (2) the fingerstick capillary blood glucose (BG) reference for pediatric participants aged 4 and 5 years. The analytical performance of the third-generation factory-calibrated FSL3 CGM system was compared to the plasma venous blood glucose reference using the YSI 2300 STAT PLUS Glucose and Lactate Analyzer (the YSI reference) and the self-monitoring blood glucose (SMBG) reference for participants aged >= 6 years and participants aged 4 and 5 years, respectively.MethodsA total of 108 participants aged >= 4 years with type 1 or type 2 diabetes from four sites in the USA were enrolled in the study. The data of 100 participants were ultimately evaluated. Adult participants (aged >= 18 years) participated in three in-clinic sessions, and pediatric participants (aged 4-17 years) participated in up to two in-clinic sessions, all stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13 or 14 of sensor wear. Performance evaluation included accuracy measures, such as proportion of CGM values that fell within +/- 20% or +/- 20 mg/dL (1.1 mmol/L) of the reference glucose values, and difference measures, such as the mean absolute relative difference (MARD) between the CGM and reference values.ResultsData from the 100 study participants were analyzed. The overall MARD was 7.8%, and 93.4% of the CGM values were within +/- 20% or +/- 20 mg/dL of the YSI reference for participants aged >= 6 years, with 6845 CGM-YSI matched pairs. The performance was stable over the 14-day wear period. For participants aged 4-5 years, MARD was 10.0%, and 88.9% of the CGM values were within 20%/20 mg/dL compared to a SMBG reference. No serious adverse events were reported.ConclusionsThe FSL3 CGM system demonstrated accurate performance across the dynamic glycemic range during the 14-day sensor wear period.
引用
收藏
页码:767 / 776
页数:10
相关论文
共 50 条
  • [42] Accuracy of continuous glucose monitoring system during exercise in type 2 diabetes
    Figueira, Franciele R.
    Umpierre, Daniel
    Ribeiro, Jorge P.
    Tetelbom, Pedro S.
    Henn, Nicoli T.
    Esteves, Jorge F.
    Schaan, Beatriz D.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 98 (03) : E36 - E39
  • [43] The accuracy of continuous glucose monitoring system by the athlete with diabetes mellitus type 1
    Vokounova-Honsova, Sarka
    Navratil, Tomas
    Kohlikova, Eva
    MONATSHEFTE FUR CHEMIE, 2018, 149 (09): : 1659 - 1669
  • [44] Influence of time-point of calibration on accuracy of a continuous glucose monitoring system
    Zueger, T.
    Krull, I.
    Mougiakakou, S.
    Diem, P.
    Stettler, C.
    DIABETOLOGIA, 2011, 54 : S396 - S396
  • [45] Accuracy of real-time continuous glucose monitoring in the MiniMed paradigm system
    Mastrototaro, John
    Soundararajan, Gopikrishnan
    Cooper, Ken
    Shah, Rajiv
    DIABETES, 2007, 56 : A112 - A112
  • [46] The accuracy of continuous glucose monitoring system by the athlete with diabetes mellitus type 1
    Šárka Vokounová-Honsová
    Tomáš Navrátil
    Eva Kohlíková
    Monatshefte für Chemie - Chemical Monthly, 2018, 149 : 1659 - 1669
  • [47] Impact of Body Composition on the Accuracy of a Medtronic Guardian Continuous Glucose Monitoring System
    Abraham, Mary B.
    Smith, Grant J.
    Choo, Ace Y. L.
    de Bock, Martin
    Davis, Elizabeth A.
    Jones, Timothy W.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (08) : 549 - 553
  • [48] Comparison of continuous 24-hour and 14-day ECG monitoring for the detection of cardiac arrhythmias in patients with ischemic stroke or syncope
    Chen, Wei-Cheng
    Wu, Yu-Lin
    Hsu, Yu-Cheng
    Hsu, Jen-Te
    Tseng, Hung-Pin
    Chen, Chao-Chin
    Chiang, Meng-Hsiu
    Hsiao, Ju-Feng
    Chin, See-Khong
    Huang, Ying-Li
    Lei, Meng-Huan
    CLINICAL CARDIOLOGY, 2024, 47 (03)
  • [49] A PHASE-1 TRIAL OF 14-DAY CONTINUOUS INTRAVENOUS-INFUSION MITOXANTRONE
    KREISLE, WH
    ALBERTS, DS
    LIST, AF
    MCCLOSKEY, T
    PLEZIA, P
    PENG, YM
    GEORGE, M
    ANTI-CANCER DRUGS, 1991, 2 (03) : 251 - 259
  • [50] Arrhythmia Detection is Improved by 14-Day Continuous Electrocardiography Patch Monitoring and CHA2DS2-VASc Score
    Cheng, Yu-Wen
    Wu, Lung-Sheng
    Wu, Chia-Tung
    Lin, Chia-Pin
    Chu, Pao-Hsien
    ACTA CARDIOLOGICA SINICA, 2022, 38 (01) : 64 - 72